Healthy Volunteers (Diabetes Mellitus, Type 2)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Healthy Volunteers (Diabetes Mellitus, Type 2) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Healthy Volunteers (Diabetes Mellitus, Type 2) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study will evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single ascending doses (SAD) and multiple ascending doses (MA…
The main objective of this trial is to assess the safety and tolerability of AMG 127 as single dose and multiple doses in healthy participants and participants…
The purpose of this study is to measure the pharmacokinetics (PK-how the body processes the study drug) of elecoglipron in healthy participants when taken by mo…
The aim of the study is to investigate the effect of partial replacement of wheat flour by legume flour of different particle sizes on postprandial glucose resp…
This study is testing a new medicine that might help treat people with type 2 diabetes. The study is conducted to see if the new medicine can lower high sugar l…
Phase 1 Safety and Relative Bioavailability Study of DWRX5003 in Healthy Adults
To investigate safety and tolerability of HTD4010 after single ascending doses (SAD) in healthy volunteers
Background: * Vitamin E is an antioxidant that reduces the damaging effects of oxygen in the body. Most American men (90%) and women (96%) do not get enough vi…